Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular Disease
Amand F Schmidt, Nicholas B Hunt, Maria Gordillo-Marañón, Pimphen Charoen, Fotios Drenos, Juan-Pablo Casas, Mika Kivimaki, Deborah A Lawlor, Claudia Giambartolomei, Olia Papacosta, Nishi Chaturvedi, Joshua C Bis, UCLEB consortium, Christopher O’Donnell, Goya Wannamethee, Andrew Wong, Jackie F Price, Alun D Hughes, Tom R Gaunt, Nora Franceschini, Dennis O Mook-Kanamori, Magdalena Zwierzyna, Reecha Sofat, Aroon D Hingorani, Chris Finan
doi: https://doi.org/10.1101/2020.09.07.20189571
Amand F Schmidt
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
bUCL British Heart Foundation Research Accelerator
cDepartment of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands
Nicholas B Hunt
dDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands
Maria Gordillo-Marañón
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
bUCL British Heart Foundation Research Accelerator
Pimphen Charoen
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
eDepartment of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
fIntegrative Computational BioScience (ICBS) Center, Mahidol University, Bangkok 10400, Thailand
Fotios Drenos
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
gDepartment of Life Sciences, College of Health, Medicine, and Life Sciences, Brunel University London, Uxbridge, United Kingdom
Juan-Pablo Casas
hDepartment of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
iMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA
Mika Kivimaki
jDepartment of Epidemiology and Public Health, University College London, London WC1E 6BT, UK
Deborah A Lawlor
kMRC Integrative Epidemiology Unit at the University of Bristol, Bristol BS8 2BN, UK
lPopulation Health, Bristol Medical School, University of Bristol
mBristol NIHR Bristol Biomedical Research Centre, University Hospitals Bristol National Health Service Foundation Trust and University of Bristol, Bristol, UK
Claudia Giambartolomei
nIstituto Italiano di Tecnologia, Central RNA Lab, Genova, Italy
oDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA
Olia Papacosta
pPrimary Care and Population Health, University College London, London, UK
Nishi Chaturvedi
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
Joshua C Bis
qCardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA
Christopher O’Donnell
rDepartment of Medicine, VA Boston Healthcare System, Boston, Massachusetts
Goya Wannamethee
pPrimary Care and Population Health, University College London, London, UK
Andrew Wong
sMRC Unit for Lifelong Health and Ageing, London, UK
Jackie F Price
tUsher Institute, University of Edinburgh, EH8 9AG, UK
Alun D Hughes
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
sMRC Unit for Lifelong Health and Ageing, London, UK
Tom R Gaunt
kMRC Integrative Epidemiology Unit at the University of Bristol, Bristol BS8 2BN, UK
lPopulation Health, Bristol Medical School, University of Bristol
mBristol NIHR Bristol Biomedical Research Centre, University Hospitals Bristol National Health Service Foundation Trust and University of Bristol, Bristol, UK
Nora Franceschini
uDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27516
Dennis O Mook-Kanamori
vDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
Magdalena Zwierzyna
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
bUCL British Heart Foundation Research Accelerator
Reecha Sofat
wInstitute of Health Informatics, University College London, London WC1 E 6BT, United Kingdom
Aroon D Hingorani
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
bUCL British Heart Foundation Research Accelerator
xHealth Data Research UK, London
Chris Finan
aInstitute of Cardiovascular Science, Faculty of Population Health, University College London, London WC1E 6BT, United Kingdom
bUCL British Heart Foundation Research Accelerator
cDepartment of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands

Data Availability
All data are publicly available, as described in the methods section. Please contact AFS for access to specific files, data, or analysis scripts.
Posted September 16, 2020.
Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular Disease
Amand F Schmidt, Nicholas B Hunt, Maria Gordillo-Marañón, Pimphen Charoen, Fotios Drenos, Juan-Pablo Casas, Mika Kivimaki, Deborah A Lawlor, Claudia Giambartolomei, Olia Papacosta, Nishi Chaturvedi, Joshua C Bis, UCLEB consortium, Christopher O’Donnell, Goya Wannamethee, Andrew Wong, Jackie F Price, Alun D Hughes, Tom R Gaunt, Nora Franceschini, Dennis O Mook-Kanamori, Magdalena Zwierzyna, Reecha Sofat, Aroon D Hingorani, Chris Finan
medRxiv 2020.09.07.20189571; doi: https://doi.org/10.1101/2020.09.07.20189571
Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular Disease
Amand F Schmidt, Nicholas B Hunt, Maria Gordillo-Marañón, Pimphen Charoen, Fotios Drenos, Juan-Pablo Casas, Mika Kivimaki, Deborah A Lawlor, Claudia Giambartolomei, Olia Papacosta, Nishi Chaturvedi, Joshua C Bis, UCLEB consortium, Christopher O’Donnell, Goya Wannamethee, Andrew Wong, Jackie F Price, Alun D Hughes, Tom R Gaunt, Nora Franceschini, Dennis O Mook-Kanamori, Magdalena Zwierzyna, Reecha Sofat, Aroon D Hingorani, Chris Finan
medRxiv 2020.09.07.20189571; doi: https://doi.org/10.1101/2020.09.07.20189571
Subject Area
Subject Areas
- Addiction Medicine (243)
- Allergy and Immunology (524)
- Anesthesia (125)
- Cardiovascular Medicine (1432)
- Dermatology (158)
- Emergency Medicine (292)
- Epidemiology (10326)
- Gastroenterology (533)
- Genetic and Genomic Medicine (2652)
- Geriatric Medicine (255)
- Health Economics (499)
- Health Informatics (1744)
- Health Policy (791)
- Hematology (269)
- HIV/AIDS (570)
- Medical Education (276)
- Medical Ethics (83)
- Nephrology (291)
- Neurology (2479)
- Nursing (145)
- Nutrition (381)
- Oncology (1332)
- Ophthalmology (403)
- Orthopedics (152)
- Otolaryngology (239)
- Pain Medicine (172)
- Palliative Medicine (51)
- Pathology (344)
- Pediatrics (785)
- Primary Care Research (296)
- Public and Global Health (5029)
- Radiology and Imaging (900)
- Respiratory Medicine (687)
- Rheumatology (309)
- Sports Medicine (246)
- Surgery (300)
- Toxicology (45)
- Transplantation (141)
- Urology (108)